The contraceptives market based on hormones or spermicides in Chile has faced fluctuations over the past decade. After peaking in 2013 at $142.7M, a significant downturn followed, bottoming at $112.75M in 2017. A notable recovery occurred in 2018 with a 20.05% increase to $135.35M. The market somewhat stabilized but showed a declining trend, reaching $123.06M in 2023. The last five years reflect a slight downturn, with a forecasted CAGR of -0.51% through 2028, indicating a modest but consistent decline.
Future trends to watch include the potential rise in demand from increased awareness and education on reproductive health, alongside the introduction of innovative contraceptive products. Healthcare policies and economic factors will also play critical roles in shaping market dynamics.